Adrian Newman-Tancredi
is co-founder and
Chief Scientific Officer
of Neurolixis Inc.
Find out more here.
 

Newsletter Subscription

Enter Name and Email

News

NeuroAct Communication advances its consulting assignments, scientific communication and online presence.
You can keep up to date with latest news by regularly checking announcements on this page.

To receive occasional Newsletters by email, enter your contact details.
To view previous Newsletters click here.

 

Title Filter 

1 28 March 2013 - Just published: pharmacology of the antidepressant Levomilnacipran
2 22 March 2013 - Lectures in USA on novel "biased agonist" drugs for depression
3 19 February 2013 - Lectures on Parkinson's disease and Depression
4 08 January 2013 - Watch Adrian's ECNP lecture on webcast
5 28 December 2012 - Adrian gives psychopharmacology lectures in Netherlands
6 23 November 2012 - Lectures and PhD examination at Lyon University
7 11 October 2012 - Serotonin Club elects Adrian as new European Council member
8 03 September 2012 - Adrian to present at 25th ECNP Congress in Vienna
9 01 September 2012 - Serotonin Club Poster presentation.
10 03 July 2012 - Adrian to chair a symposium at Serotonin Club meeting
11 12 June 2012 - Adrian to present at online neuroscience webinar
12 06 June 2012 - Just published: novel PET radiotracer for brain imaging of 5-HT1A receptors
13 08 May 2012 - Adrian gives lectures and acts as PhD examiner
14 23 March 2012 - Just published: novel potential antidepressant with 5-HT2C and alpha2 actions
15 07 March 2012 - Adrian to present at AFPBN meeting in Paris
16 01 February 2012 - The Michael J. Fox Foundation awards research grant to Neurolixis
17 03 January 2012 - Adrian to present at 10th Encéphale Congress in Paris
18 02 November 2011 - Adrian gives lectures on neuropharmacology
19 03 October 2011 - Just published: Review of anatomical selectivity for Parkinson's Disease therapy
20 23 August 2011 - Just published: analgesic actions of the anti-fibromyalgia drug milnacipran
21 08 July 2011 - Launch of Neurolixis Inc.: biopharmaceutical start-up company
22 14 June 2011 - Adrian to present at 24th ECNP Congress in Paris
23 26 May 2011 - Adrian to present at Mental Disorders meeting in Santander, Spain
24 21 April 2011 - Adrian's Resume online
25 18 April 2011 - Just published: Review of "biased agonism" at 5-HT1A receptors
26 15 March 2011 - Adrian gives seminar at brain imaging center
27 14 March 2011 - Just published: Review of antipsychotics pharmacology
28 11 February 2011 - "Search" function now available on NeuroAct Communication website
29 27 January 2011 - ECNP awards Adrian fast-track society membership
30 10 December 2010 - Adrian gives lectures at academic institutions
31 19 November 2010 - Consulting assignments completed
32 15 September 2010 - Watch Adrian's ECNP lecture on webcast
33 06 August 2010 - Just published: Central 5-HT2B antagonists control dopamine release
34 03 August 2010 - Adrian to present at ECNP in Amsterdam
35 01 July 2010 - Just published: Review of 5-HT1A action of antipsychotics
36 14 June 2010 - NeuroAct Communication is now online
37 5 June 2010 - Adrian to speak at Poznan ECNP
38 25 May 2010 - Just published: articles on a new-generation 5-HT1A agonist